方邦股份(688020) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥76,150,695.23, representing a decrease of 20.70% compared to the same period last year[5] - The net profit attributable to shareholders was -¥21,767,609.43, a decline of 72.77% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥26,988,109.85, down 70.93% from the previous year[5] - Total operating revenue for Q1 2023 was CNY 76,150,695.23, a decrease of 20.5% compared to CNY 96,030,883.93 in Q1 2022[21] - Net profit for Q1 2023 was a loss of CNY 21,090,223.52, compared to a loss of CNY 11,502,941.75 in Q1 2022, representing an increase in loss of 83.5%[22] - The company's total revenue for Q1 2023 was ¥47,033,949.07, a decrease of 40.5% compared to ¥79,270,947.57 in Q1 2022[33] - The company's net profit for Q1 2023 was ¥928,420.35, down from ¥2,312,605.29 in Q1 2022, reflecting a decline of 59.9%[33] - The company reported a total comprehensive income of ¥928,420.35 for Q1 2023[34] Research and Development - The total R&D investment amounted to ¥13,051,519.46, which is a decrease of 43.32% compared to the same period last year[6] - R&D investment accounted for 17.14% of operating revenue, a decrease of 6.84 percentage points year-on-year[6] - Research and development expenses for Q1 2023 were CNY 13,051,519.46, a decrease of 43.1% from CNY 23,025,905.74 in Q1 2022[22] - Research and development expenses for Q1 2023 were ¥8,096,335.48, a decrease of 48.9% from ¥15,857,467.60 in Q1 2022[33] - The company plans to gradually increase trial and production activities in R&D as new product and technology development progresses[10] Cash Flow and Assets - The cash flow from operating activities was -¥32,737,017.82, indicating a negative cash flow situation[6] - Cash flow from operating activities for Q1 2023 was a net outflow of CNY 32,737,017.82, an improvement from a net outflow of CNY 35,561,896.00 in Q1 2022[26] - The net cash flow from operating activities for Q1 2023 was ¥2,167,245.73, a significant improvement from a net loss of ¥49,371,836.07 in Q1 2022[37] - The net cash flow from investing activities was -¥163,007,055.33, compared to a positive cash flow of ¥72,627,529.53 in Q1 2022[37] - The cash inflow from investment activities in Q1 2023 was CNY 881,882,722.26, an increase from CNY 825,071,966.67 in Q1 2022[26] - Cash and cash equivalents were reported at CNY 311,471,249.43, down from CNY 468,084,888.88[17] - Cash and cash equivalents at the end of Q1 2023 were ¥299,295,909.11, down from ¥428,630,378.76 at the end of Q1 2022[27] - The total assets as of March 31, 2023, amounted to ¥1,961,260,397.20, a slight increase from ¥1,945,163,534.68 at the end of 2022[29] - Current assets totaled CNY 1,023,301,322.12, showing a marginal increase from CNY 1,020,684,733.00 in the previous period[17] Liabilities and Equity - The company's total liabilities as of Q1 2023 were CNY 415,510,915.84, compared to CNY 407,724,546.60 in the previous quarter[24] - The total equity attributable to shareholders was CNY 1,524,057,200.09, a decrease from CNY 1,544,140,869.74 in the previous quarter[24] - The company's long-term equity investments remained stable at ¥200,187,451.50, compared to ¥200,137,344.99 at the end of 2022[30] - The company's short-term borrowings increased to CNY 163,998,771.40 from CNY 132,310,157.17[18] - Accounts payable decreased to CNY 139,173,131.08 from CNY 167,231,222.26, indicating improved cash flow management[18] - No significant changes in long-term liabilities were reported, maintaining stability in the company's financial structure[18] Shareholder Information - The company reported a total of 47.61% ownership by the top shareholders, indicating strong control over the company[14] - Basic and diluted earnings per share for Q1 2023 were both CNY -0.27, compared to CNY -0.16 in Q1 2022[23] General Observations - The company experienced a significant decline in sales volume of shielding films, impacting overall revenue and profit margins[10] - The company has not disclosed any significant new product developments or market expansion strategies in the current report[15] - The financial statements are unaudited, which may affect investor confidence[15] - The total cash outflow from operating activities was ¥43,354,692.69, down 65.3% from ¥124,794,741.71 in Q1 2022[36] - The cash flow from financing activities was ¥34,045,082.23, an increase from ¥4,844,235.61 in Q1 2022[37] - The company plans to continue its investment strategy despite the negative cash flow from investing activities[37]